About BrainOmega

The Generative AI company for pharma and biotech.

BrainOmega builds foundation models that design and evaluate new medicines in software, so research teams can spend their lab time and budget on the candidates most likely to work.

Founded 2026 Headquartered in Barcelona Drug and RNA discovery
Who we are

Moving more of drug discovery into software.

BrainOmega is a Generative AI company working across pharma and biotech. We build our own foundation models for chemistry and RNA biology, and put them to work in two products: Drug Discovery, for small-molecule programmes, and RNA Discovery, for research across RNA classes.

Bringing a medicine to patients takes many years, and most candidates fail along the way, often late and at great cost. We believe much more of that work can happen in software, where ideas are faster to test, cheaper to discard and easier to check.

That is what our platform is for: generating candidates, evaluating them on the properties that decide their fate, and showing the evidence behind every result, so scientists can make decisions they are able to defend.

Mission and vision

Why we exist, and where we are going.

Our mission

To help research teams bring better medicines to patients sooner, by designing and evaluating them in software before they reach the lab.

Our vision

A future in which every promising medicine is designed, tested and understood in software before the first experiment, and every prediction can be traced back to its evidence.

What we do

Foundation models, put to work in two products.

One platform, one sign-in, and the same standard of evidence for small molecules and RNA.

Foundation models

Built and trained in-house for chemistry and RNA biology. They generate candidates, predict their properties and report how confident each prediction is.

Drug Discovery

Identify targets, design and explore molecules in 3D, and prioritise candidates for further testing.

Open Drug Discovery

RNA Discovery

Characterise a sequence or scan public data for new candidates across RNA classes, with the rule and evidence behind every verdict.

Open RNA Discovery
How we work

Four principles behind everything we build.

Scientific rigour

We validate our models against real data and say how each result was tested. A prediction is only as good as its validation.

Evidence first

Every value comes from a reproducible pipeline and shows its sources. Missing data is reported as missing, never as a negative.

Rooted in Europe

Headquartered in Barcelona and built with Europe's universities, public bodies and supercomputing centres.

Scientists in the loop

Our tools support chemists and biologists; they do not replace them. People make the decisions.

Our story

A young company, moving quickly.

  1. 2026

    Founded in Barcelona

    BrainOmega starts with one question: how much of drug discovery can be done well in software?

  2. 2026

    Foundation models

    Our own models for chemistry and RNA biology, trained and validated in-house.

  3. 2026

    Two products live

    Drug Discovery and RNA Discovery open to research teams at oncomega.app.

  4. Next

    Growing with partners

    More programmes with pharma and biotech, and new modalities on the same platform.

Our partners

Built with Catalonia's research and innovation ecosystem.

Universities, public bodies, supercomputing centres and specialist advisers we work alongside.

Build the future of drug discovery with us.

We are looking for scientists, engineers and business people who want to change how medicines are discovered. Partners and investors are welcome to get in touch too.